严重自发性非脑出血的发生率与血管内治疗:单中心经验
该单中心回顾性分析2016年1月至2017年6月共44例严重自发性非脑出血患者,年发生率29.3例;37/44例(84.1%)出血归因于抗血栓治疗。仅CT血管成像显示活动性出血者行血管内治疗(EVT组19例),无活动性出血者保守治疗(CM组25例);EVT技术成功率100%,无EVT相关并发症,两组6个月生存率分别为42.1%与58.3%。
要点
- 严重自发性非脑出血年发生率29.3例,84.1%(37/44)与抗血栓治疗相关。
- 仅CTA显示活动性出血者行EVT,技术成功率100%,无EVT相关并发症。
- EVT组与CM组6个月生存率分别为42.1%与58.3%,死亡率高主要归因于严重合并症。
核心结论
- 本机构严重自发性非脑出血年发生率较高;EVT实现无并发症的高止血控制率;EVT或保守治疗后死亡率均较高,主要归因于严重合并症。
研究设计与样本
- 单中心回顾性分析,2016年1月至2017年6月共纳入44例严重自发性非脑出血患者;以CT血管成像(CTA)显示活动性出血为EVT入选条件,无活动性出血者行保守治疗。
诊断标准与关键数值
- EVT仅用于CTA显示活动性出血的患者;EVT技术成功率100%;EVT后出血复发1例(5.2%,腰椎动脉栓塞后),经再次栓塞成功。
临床应用与阅片要点
- CTA显示活动性出血的严重自发性非脑出血患者可行血管内治疗,技术成功率高且无EVT相关并发症;无活动性出血者按原文设计行保守治疗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To investigate the incidence and endovascular treatment of severe spontaneous non-cerebral hemorrhage (SSNCH) in a high-volume, tertiary university hospital.
METHODS: All patients diagnosed with SSNCH between January 2016 and June 2017 were retrospectively analyzed. Endovascular treatment (group EVT) was offered only in patients demonstrating active bleeding at CT angiography (CTA). In cases without active bleeding at CTA, conservative management was decided (group CM). Outcome measures included the incidence of SSNCH, 6-month rebleeding, and survival rates in the two groups as well as EVT technical success and related complications.
RESULTS: Within the 18-month period, 44 SSNCH cases were identified, resulting in an annual incidence of 29.3 cases. In 37/44 cases (84.1%), bleeding was attributed to the antithrombotic therapy. In total, 19/44 patients underwent EVT (43.2%), and 25/44 patients (56.8%) were managed conservatively. Two patients who were initially treated conservatively finally underwent EVT due to rebleeding (7.4%). The technical success of EVT was 100%, while rebleeding occurred in 1 case (5.2%) following lumbar artery embolization and was successfully re-embolized. According to the Kaplan-Meier analysis, the 1-, 3-, and 6-month survival rates were 68.4%, 63.2%, and 42.1% for group EVT and 87.5%, 75.0%, and 58.3% for group CM, respectively. There were no EVT-related complications.
CONCLUSIONS: The annual incidence of SSNCH in our institution is substantial. EVT resulted in uncomplicated, high bleeding control rates. The mortality rate was similarly high following either EVT or conservative treatment and was mainly attributed to severe comorbidities.
KEY POINTS: • This study demonstrates that the incidence of severe spontaneous non-cerebral hemorrhage (SSNCH) in our institution is substantial. • Endovascular treatment was offered only in patients with clinical signs of ongoing hemorrhage and active bleeding at CT angiography and resulted in effective and uncomplicated, minimal invasive hemostasis, in a population with severe comorbidities. • This is the first study to evaluate the outcomes of both endovascular hemostasis and conservative management. Rebleeding following either conservative or endovascular treatment was minimal.
引用
- Spiliopoulos S, Festas G, Theodosis A, et al. Incidence and endovascular treatment of severe spontaneous non-cerebral bleeding: a single-institution experience. Eur Radiol. 2018. PMID: 30519935. doi:10.1007/s00330-018-5869-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。